Toll-like receptor-4 antagonist (+)-naloxone elicits sexually dimorphic attenuation of inflammation-induced fetal programming in mice. Supplemental Tables 1-5

Loretta Chin, Camilla Dorian, Mark Hutchinson, Sarah Robertson
2019
Supplemental Tables S1-S5 from:Toll-like receptor-4 antagonist (+)-naloxone elicits sexually dimorphic attenuation of inflammation-induced fetal programming in miceChin P-Y, Dorian C, Sharkey DJ, Hutchinson MR, Rice KC, Moldenhauer LM, Robertson SA.
doi:10.25909/5d0c35fb15657 fatcat:g5ktmi4jlzdnrkgjgewbchdk3q